← Open Payments lookup

ELIZABETH RAUSCHENBERG: Open Payments

NPI 1548770985 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,978 in 49 payments from 24 companies in 2025. Trend: 2023 $653 · 2024 $1,880 · 2025 $1,978

Long term medical supply or device loan: $1,000Food & beverage: $878Education: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation17$1,124
Daiichi Sankyo Inc.3$155
ABBVIE INC.3$98
Merck Sharp & Dohme LLC3$85
Janssen Biotech, Inc.3$82
AstraZeneca Pharmaceuticals LP2$50
PharmaEssentia USA Corporation1$32
Bayer Healthcare Pharmaceuticals Inc.1$28
Syndax Pharmaceuticals, Inc.1$28
BeiGene USA, Inc.1$27

Products named: KISQALI, Enhertu, KEYTRUDA, ELAHERE, SCEMBLIX, TECVAYLI, BESREMI, EPKINLY.

Industry payments across DC — which companies pay providers there.